168 related articles for article (PubMed ID: 2248955)
21. An Arg/Ser substitution in the second epidermal growth factor-like module of factor IX introduces an O-linked carbohydrate and markedly impairs activation by factor XIa and factor VIIa/Tissue factor and catalytic efficiency of factor IXa.
Hertzberg MS; Facey SL; Hogg PJ
Blood; 1999 Jul; 94(1):156-63. PubMed ID: 10381508
[TBL] [Abstract][Full Text] [Related]
22. The tissue factor region that interacts with substrates factor IX and Factor X.
Kirchhofer D; Lipari MT; Moran P; Eigenbrot C; Kelley RF
Biochemistry; 2000 Jun; 39(25):7380-7. PubMed ID: 10858285
[TBL] [Abstract][Full Text] [Related]
23. Phospholipid surfaces regulate the delivery of substrate to tissue factor:VIIa and the removal of product.
Hathcock JJ; Rusinova E; Andree H; Nemerson Y
Blood Cells Mol Dis; 2006; 36(2):194-8. PubMed ID: 16529959
[TBL] [Abstract][Full Text] [Related]
24. Factor IX Fukuoka. Substitution of ASN92 by His in the second epidermal growth factor-like domain results in defective interaction with factors VIIa/X.
Nishimura H; Takeya H; Miyata T; Suehiro K; Okamura T; Niho Y; Iwanaga S
J Biol Chem; 1993 Nov; 268(32):24041-6. PubMed ID: 8226948
[TBL] [Abstract][Full Text] [Related]
25. Phospholipid-independent and -dependent interactions required for tissue factor receptor and cofactor function.
Ruf W; Rehemtulla A; Morrissey JH; Edgington TS
J Biol Chem; 1991 Feb; 266(4):2158-66. PubMed ID: 1989976
[TBL] [Abstract][Full Text] [Related]
26. Tissue factor residues that putatively interact with membrane phospholipids.
Ke K; Yuan J; Morrissey JH
PLoS One; 2014; 9(2):e88675. PubMed ID: 24516673
[TBL] [Abstract][Full Text] [Related]
27. The interactions of factors X and IX with phospholipid.
Bloom JW
Thromb Res; 1989 May; 54(4):261-8. PubMed ID: 2763266
[TBL] [Abstract][Full Text] [Related]
28. Cofactor residues lysine 165 and 166 are critical for protein substrate recognition by the tissue factor-factor VIIa protease complex.
Ruf W; Miles DJ; Rehemtulla A; Edgington TS
J Biol Chem; 1992 Mar; 267(9):6375-81. PubMed ID: 1372908
[TBL] [Abstract][Full Text] [Related]
29. Phospholipid regulates the activation of factor X by tissue factor/factor VIIa (TF/VIIa) via substrate and product interactions.
Hathcock JJ; Rusinova E; Gentry RD; Andree H; Nemerson Y
Biochemistry; 2005 Jun; 44(22):8187-97. PubMed ID: 15924438
[TBL] [Abstract][Full Text] [Related]
30. The role of phospholipids and the factor VII Gla-domain in the interaction of factor VII with tissue factor.
Wildgoose P; Jørgensen T; Komiyama Y; Nakagaki T; Pedersen A; Kisiel W
Thromb Haemost; 1992 Jun; 67(6):679-85. PubMed ID: 1509409
[TBL] [Abstract][Full Text] [Related]
31. Intrinsic versus extrinsic coagulation. Kinetic considerations.
Warn-Cramer BJ; Bajaj SP
Biochem J; 1986 Nov; 239(3):757-62. PubMed ID: 3493767
[TBL] [Abstract][Full Text] [Related]
32. The crystal structure of the complex of blood coagulation factor VIIa with soluble tissue factor.
Banner DW; D'Arcy A; Chène C; Winkler FK; Guha A; Konigsberg WH; Nemerson Y; Kirchhofer D
Nature; 1996 Mar; 380(6569):41-6. PubMed ID: 8598903
[TBL] [Abstract][Full Text] [Related]
33. Role of the membrane surface in the activation of human coagulation factor X.
Krishnaswamy S; Field KA; Edgington TS; Morrissey JH; Mann KG
J Biol Chem; 1992 Dec; 267(36):26110-20. PubMed ID: 1464622
[TBL] [Abstract][Full Text] [Related]
34. Kinetics of coagulation factor X activation by platelet-bound factor IXa.
Rawala-Sheikh R; Ahmad SS; Ashby B; Walsh PN
Biochemistry; 1990 Mar; 29(10):2606-11. PubMed ID: 2110473
[TBL] [Abstract][Full Text] [Related]
35. Ability of recombinant factor VIIa to generate thrombin during inhibition of tissue factor in human subjects.
Friederich PW; Levi M; Bauer KA; Vlasuk GP; Rote WE; Breederveld D; Keller T; Spataro M; Barzegar S; Büller HR
Circulation; 2001 May; 103(21):2555-9. PubMed ID: 11382723
[TBL] [Abstract][Full Text] [Related]
36. Activation of human factor VII in the initiation of tissue factor-dependent coagulation.
Rao LV; Rapaport SI; Bajaj SP
Blood; 1986 Sep; 68(3):685-91. PubMed ID: 3488776
[TBL] [Abstract][Full Text] [Related]
37. Flow dependence of factor X activation by tissue factor-factor VIIa.
Contino PB; Andree HA; Nemerson Y
J Physiol Pharmacol; 1994 Mar; 45(1):81-90. PubMed ID: 8043911
[TBL] [Abstract][Full Text] [Related]
38. Molecular interactions of the intrinsic activation complex of coagulation: binding of native and activated human factors IX and X to defined phospholipid vesicles.
Burri BJ; Edgington TS; Fair DS
Biochim Biophys Acta; 1987 Feb; 923(2):176-86. PubMed ID: 3493031
[TBL] [Abstract][Full Text] [Related]
39. Characterization of functionally important regions of tissue factor by using monoclonal antibodies.
Ito T; Hiraiwa J; Nishioka J; Iino M; Suzuki K
J Biochem; 1993 Nov; 114(5):691-6. PubMed ID: 8113222
[TBL] [Abstract][Full Text] [Related]
40. Expression and characterization of human factor IX and factor IX-factor X chimeras in mouse C127 cells.
Lin SW; Smith KJ; Welsch D; Stafford DW
J Biol Chem; 1990 Jan; 265(1):144-50. PubMed ID: 2294100
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
